ALCON INC (2U3.DE) Stock Fundamental Analysis
Europe - FRA:2U3 - CH0432492467 - Common Stock
66.92 EUR
-1.3 (-1.91%)
We assign a fundamental rating of 5 out of 10 to 2U3. 2U3 was compared to 60 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and the financial health of 2U3 get a neutral evaluation. Nothing too spectacular is happening here. 2U3 has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year 2U3 was profitable.
In the past year 2U3 had a positive cash flow from operations.
2U3 had positive earnings in 4 of the past 5 years.
2U3 had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
2U3's Return On Assets of 3.42% is in line compared to the rest of the industry. 2U3 outperforms 50.82% of its industry peers.
2U3 has a Return On Equity (4.85%) which is comparable to the rest of the industry.
The Return On Invested Capital of 2U3 (3.87%) is worse than 62.30% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for 2U3 is significantly below the industry average of 8.99%.
The last Return On Invested Capital (3.87%) for 2U3 is above the 3 year average (3.01%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.42% | ||
| ROE | 4.85% | ||
| ROIC | 3.87% |
ROA(3y)2.6%
ROA(5y)1.44%
ROE(3y)3.72%
ROE(5y)2.06%
ROIC(3y)3.01%
ROIC(5y)N/A
1.3 Margins
The Profit Margin of 2U3 (10.70%) is better than 72.13% of its industry peers.
2U3's Profit Margin has improved in the last couple of years.
2U3 has a better Operating Margin (13.81%) than 68.85% of its industry peers.
2U3's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 54.26%, 2U3 is in line with its industry, outperforming 50.82% of the companies in the same industry.
In the last couple of years the Gross Margin of 2U3 has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 13.81% | ||
| PM (TTM) | 10.7% | ||
| GM | 54.26% |
OM growth 3Y6.79%
OM growth 5Y35.45%
PM growth 3Y31.33%
PM growth 5YN/A
GM growth 3Y-0.59%
GM growth 5Y2.7%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so 2U3 is destroying value.
2U3 has more shares outstanding than it did 1 year ago.
2U3 has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, 2U3 has an improved debt to assets ratio.
2.2 Solvency
2U3 has an Altman-Z score of 4.11. This indicates that 2U3 is financially healthy and has little risk of bankruptcy at the moment.
2U3 has a better Altman-Z score (4.11) than 75.41% of its industry peers.
The Debt to FCF ratio of 2U3 is 3.71, which is a good value as it means it would take 2U3, 3.71 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 3.71, 2U3 is in the better half of the industry, outperforming 68.85% of the companies in the same industry.
2U3 has a Debt/Equity ratio of 0.23. This is a healthy value indicating a solid balance between debt and equity.
2U3's Debt to Equity ratio of 0.23 is fine compared to the rest of the industry. 2U3 outperforms 63.93% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.23 | ||
| Debt/FCF | 3.71 | ||
| Altman-Z | 4.11 |
ROIC/WACC0.83
WACC4.68%
2.3 Liquidity
2U3 has a Current Ratio of 2.60. This indicates that 2U3 is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.60, 2U3 is in the better half of the industry, outperforming 72.13% of the companies in the same industry.
A Quick Ratio of 1.61 indicates that 2U3 should not have too much problems paying its short term obligations.
2U3 has a better Quick ratio (1.61) than 68.85% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.6 | ||
| Quick Ratio | 1.61 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 5.23% over the past year.
Measured over the past years, 2U3 shows a quite strong growth in Earnings Per Share. The EPS has been growing by 10.04% on average per year.
Looking at the last year, 2U3 shows a small growth in Revenue. The Revenue has grown by 4.04% in the last year.
The Revenue has been growing slightly by 5.71% on average over the past years.
EPS 1Y (TTM)5.23%
EPS 3Y12.36%
EPS 5Y10.04%
EPS Q2Q%2.7%
Revenue 1Y (TTM)4.04%
Revenue growth 3Y6.13%
Revenue growth 5Y5.71%
Sales Q2Q%3.25%
3.2 Future
The Earnings Per Share is expected to grow by 11.32% on average over the next years. This is quite good.
Based on estimates for the next years, 2U3 will show a small growth in Revenue. The Revenue will grow by 6.21% on average per year.
EPS Next Y1.39%
EPS Next 2Y7.29%
EPS Next 3Y10.07%
EPS Next 5Y11.32%
Revenue Next Year5.28%
Revenue Next 2Y6.49%
Revenue Next 3Y6.6%
Revenue Next 5Y6.21%
3.3 Evolution
The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 25.84, 2U3 can be considered very expensive at the moment.
Based on the Price/Earnings ratio, 2U3 is valued a bit cheaper than 67.21% of the companies in the same industry.
2U3's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 25.89.
The Price/Forward Earnings ratio is 22.20, which indicates a rather expensive current valuation of 2U3.
2U3's Price/Forward Earnings ratio is in line with the industry average.
2U3 is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 34.59, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 25.84 | ||
| Fwd PE | 22.2 |
4.2 Price Multiples
2U3's Enterprise Value to EBITDA is on the same level as the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of 2U3 indicates a somewhat cheap valuation: 2U3 is cheaper than 65.57% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 27.53 | ||
| EV/EBITDA | 15.98 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
2U3 has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)18.64
PEG (5Y)2.57
EPS Next 2Y7.29%
EPS Next 3Y10.07%
5. Dividend
5.1 Amount
With a yearly dividend of 0.45%, 2U3 is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 2.36, 2U3 has a dividend in line with its industry peers.
With a Dividend Yield of 0.45, 2U3 pays less dividend than the S&P500 average, which is at 2.42.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.45% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
15.47% of the earnings are spent on dividend by 2U3. This is a low number and sustainable payout ratio.
DP15.47%
EPS Next 2Y7.29%
EPS Next 3Y10.07%
FRA:2U3 (11/14/2025, 7:00:00 PM)
66.92
-1.3 (-1.91%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners69.85%
Inst Owner ChangeN/A
Ins Owners0.12%
Ins Owner ChangeN/A
Market Cap33.44B
Revenue(TTM)10.03B
Net Income(TTM)1.07B
Analysts79
Price Target91.83 (37.22%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.45% |
Yearly Dividend0.23
Dividend Growth(5Y)N/A
DP15.47%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.12%
Min EPS beat(2)-4.26%
Max EPS beat(2)4.49%
EPS beat(4)3
Avg EPS beat(4)2.12%
Min EPS beat(4)-4.26%
Max EPS beat(4)7.68%
EPS beat(8)6
Avg EPS beat(8)1.75%
EPS beat(12)8
Avg EPS beat(12)2.4%
EPS beat(16)12
Avg EPS beat(16)4.71%
Revenue beat(2)0
Avg Revenue beat(2)-3.2%
Min Revenue beat(2)-3.43%
Max Revenue beat(2)-2.97%
Revenue beat(4)0
Avg Revenue beat(4)-2.13%
Min Revenue beat(4)-3.43%
Max Revenue beat(4)-0.56%
Revenue beat(8)0
Avg Revenue beat(8)-1.84%
Revenue beat(12)2
Avg Revenue beat(12)-0.97%
Revenue beat(16)5
Avg Revenue beat(16)-0.17%
PT rev (1m)-0.75%
PT rev (3m)-5.8%
EPS NQ rev (1m)0.24%
EPS NQ rev (3m)-3.31%
EPS NY rev (1m)0.09%
EPS NY rev (3m)-6.14%
Revenue NQ rev (1m)0.04%
Revenue NQ rev (3m)-1.24%
Revenue NY rev (1m)-0.07%
Revenue NY rev (3m)-0.82%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 25.84 | ||
| Fwd PE | 22.2 | ||
| P/S | 3.89 | ||
| P/FCF | 27.53 | ||
| P/OCF | 18.59 | ||
| P/B | 1.76 | ||
| P/tB | 10.42 | ||
| EV/EBITDA | 15.98 |
EPS(TTM)2.59
EY3.87%
EPS(NY)3.01
Fwd EY4.5%
FCF(TTM)2.43
FCFY3.63%
OCF(TTM)3.6
OCFY5.38%
SpS17.22
BVpS37.99
TBVpS6.42
PEG (NY)18.64
PEG (5Y)2.57
Graham Number47.05
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.42% | ||
| ROE | 4.85% | ||
| ROCE | 4.78% | ||
| ROIC | 3.87% | ||
| ROICexc | 4.07% | ||
| ROICexgc | 12.21% | ||
| OM | 13.81% | ||
| PM (TTM) | 10.7% | ||
| GM | 54.26% | ||
| FCFM | 14.11% |
ROA(3y)2.6%
ROA(5y)1.44%
ROE(3y)3.72%
ROE(5y)2.06%
ROIC(3y)3.01%
ROIC(5y)N/A
ROICexc(3y)3.18%
ROICexc(5y)N/A
ROICexgc(3y)10.24%
ROICexgc(5y)N/A
ROCE(3y)3.72%
ROCE(5y)N/A
ROICexgc growth 3Y2.95%
ROICexgc growth 5Y30.08%
ROICexc growth 3Y10.31%
ROICexc growth 5Y41.26%
OM growth 3Y6.79%
OM growth 5Y35.45%
PM growth 3Y31.33%
PM growth 5YN/A
GM growth 3Y-0.59%
GM growth 5Y2.7%
F-Score5
Asset Turnover0.32
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.23 | ||
| Debt/FCF | 3.71 | ||
| Debt/EBITDA | 1.91 | ||
| Cap/Depr | 52.59% | ||
| Cap/Sales | 6.78% | ||
| Interest Coverage | 7.52 | ||
| Cash Conversion | 78.26% | ||
| Profit Quality | 131.87% | ||
| Current Ratio | 2.6 | ||
| Quick Ratio | 1.61 | ||
| Altman-Z | 4.11 |
F-Score5
WACC4.68%
ROIC/WACC0.83
Cap/Depr(3y)77.98%
Cap/Depr(5y)73.14%
Cap/Sales(3y)9.96%
Cap/Sales(5y)10.48%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)5.23%
EPS 3Y12.36%
EPS 5Y10.04%
EPS Q2Q%2.7%
EPS Next Y1.39%
EPS Next 2Y7.29%
EPS Next 3Y10.07%
EPS Next 5Y11.32%
Revenue 1Y (TTM)4.04%
Revenue growth 3Y6.13%
Revenue growth 5Y5.71%
Sales Q2Q%3.25%
Revenue Next Year5.28%
Revenue Next 2Y6.49%
Revenue Next 3Y6.6%
Revenue Next 5Y6.21%
EBIT growth 1Y9.67%
EBIT growth 3Y13.34%
EBIT growth 5Y43.18%
EBIT Next Year35.35%
EBIT Next 3Y18.66%
EBIT Next 5Y13.9%
FCF growth 1Y346.37%
FCF growth 3Y104.3%
FCF growth 5Y41.96%
OCF growth 1Y81.07%
OCF growth 3Y15.59%
OCF growth 5Y17.69%
ALCON INC / 2U3.DE FAQ
What is the ChartMill fundamental rating of ALCON INC (2U3.DE) stock?
ChartMill assigns a fundamental rating of 5 / 10 to 2U3.DE.
Can you provide the valuation status for ALCON INC?
ChartMill assigns a valuation rating of 4 / 10 to ALCON INC (2U3.DE). This can be considered as Fairly Valued.
Can you provide the profitability details for ALCON INC?
ALCON INC (2U3.DE) has a profitability rating of 6 / 10.
Can you provide the financial health for 2U3 stock?
The financial health rating of ALCON INC (2U3.DE) is 6 / 10.
Is the dividend of ALCON INC sustainable?
The dividend rating of ALCON INC (2U3.DE) is 2 / 10 and the dividend payout ratio is 15.47%.